Active surveillance for prostate cancer: progress and promise

MR Cooperberg, PR Carroll, L Klotz - Journal of Clinical Oncology, 2011 - ascopubs.org
Widespread prostate-specific antigen (PSA)–based screening and aggressive treatment of
prostate cancer have reduced mortality rates substantially, but both remain controversial in …

Costs of radical prostatectomy for prostate cancer: a systematic review

C Bolenz, SJ Freedland, BK Hollenbeck, Y Lotan… - European urology, 2014 - Elsevier
Context Robot-assisted laparoscopic radical prostatectomy (RALP) has been rapidly
adopted as a new approach for radical prostatectomy (RP) in patients with prostate cancer …

Validation of a cell-cycle progression gene panel to improve risk stratification in a contemporary prostatectomy cohort

MR Cooperberg, JP Simko, JE Cowan… - Journal of Clinical …, 2013 - ascopubs.org
Purpose We aimed to validate a previously described genetic risk score, denoted the cell-
cycle progression (CCP) score, in predicting contemporary radical prostatectomy (RP) …

Genomic classifier identifies men with adverse pathology after radical prostatectomy who benefit from adjuvant radiation therapy

RB Den, K Yousefi, EJ Trabulsi, F Abdollah… - Journal of Clinical …, 2015 - ascopubs.org
Purpose The optimal timing of postoperative radiotherapy (RT) after radical prostatectomy
(RP) is unclear. We hypothesized that a genomic classifier (GC) would provide prognostic …

Prostate-specific membrane antigen targeted imaging and therapy of prostate cancer using a PSMA inhibitor as a homing ligand

SA Kularatne, K Wang, HKR Santhapuram… - Molecular …, 2009 - ACS Publications
Prostate cancer (PCa) is a major cause of mortality and morbidity in Western society today.
Current methods for detecting PCa are limited, leaving most early malignancies …

Observation versus initial treatment for men with localized, low-risk prostate cancer: a cost-effectiveness analysis

JH Hayes, DA Ollendorf, SD Pearson… - Annals of internal …, 2013 - acpjournals.org
Chinese translation Background: Observation is underutilized among men with localized,
low-risk prostate cancer. Objective: To assess the costs and benefits of observation versus …

Clinical events in prostate cancer lifestyle trial: results from two years of follow-up

J Frattaroli, G Weidner, AM Dnistrian, C Kemp… - Urology, 2008 - Elsevier
OBJECTIVES: Previous research has demonstrated that patients with prostate cancer
participating in the Prostate Cancer Lifestyle Trial had a reduction in prostate-specific …

Financial toxicity: a potential side effect of prostate cancer treatment among Australian men

LG Gordon, SM Walker, MC Mervin… - European journal of …, 2017 - Wiley Online Library
The purpose of this study was to understand the extent, nature and variability of the current
economic burden of prostate cancer among Australian men. An online cross‐sectional …

Primary treatments for clinically localised prostate cancer: a comprehensive lifetime cost‐utility analysis

MR Cooperberg, NR Ramakrishna, SB Duff… - BJU …, 2013 - Wiley Online Library
What's known on the subject? and What does the study add? Multiple treatment alternatives
exist for localised prostate cancer, with few high‐quality studies directly comparing their …

The rise and fall of prostate brachytherapy: use of brachytherapy for the treatment of localized prostate cancer in the National Cancer Data Base

JM Martin, EA Handorf, A Kutikov, RG Uzzo… - Cancer, 2014 - Wiley Online Library
BACKGROUND Brachytherapy has been shown to be an efficacious and cost‐effective
treatment among patients with localized prostate cancer. In this study, the authors examined …